The newly renamed Hutchmed (China) Ltd., previously known as Hutchison China Meditech Ltd. (Chi-Med), plans to sell $100 million of its American depository shares at $30.50 per ADS in a private placement to funds affiliated with Baring Private Equity Asia.
HONG KONG – Onquality Pharmaceuticals LLC raised an additional $20 million from a series A+ financing round, bringing its amount of capital raised to $35 million.
Med-tech firms raising money in public or private financings, including: Bausch Health, Better Therapeutics, CA Healthcare, Carta Healthcare, CM Life Sciences III, Firefly Health, Lumiradx, Mountain Crest, Orchid, Phreesia, Privia Health Group, Vizgen.
The biopharmaceutical sector is showing no signs of slowing the pace of attracting capital. After coming off a record year, global private and public companies collectively raised $37 billion in the first quarter, indicating that it could be another bumper year for financings.
RSS
